7 hrs ago | The Argus
A charity supporter is aiming to travel 101 miles along the South Downs Way on his mobility scooter.
A charity supporter is aiming to raise A 10,000 for charity - by travelling 101 miles along the South Downs Way on his mobility scooter.
Young scientists shine in AZ competition
It is the largest high school science competition in the world and it's happening right here in the Valley.
Study identifies new approach to improving treatment for MS and other conditions
Working with lab mice models of multiple sclerosis , UC Davis scientists have detected a novel molecular target for the design of drugs that could be safer and more effective than current FDA-approved medications against MS.
Scientists successfully create human stem cells through cloning
The feat, which has been attempted without success for almost two decades, could lead to new treatments for diseases like Parkinson's and multiple sclerosis.
Hamilton motorcyclist refuses to let multiple sclerosis slow him down
Mike Pawelczak has had MS for over 30 years and leads a group of motorcycle riders, who provide support for cyclists.
Research and Markets: Laquinimod (Multiple Sclerosis) - Forecast and Market Analysis to 2022
Teva's and Active Biotech's laquinimod is a synthetic, once-daily, orally-administered immunomodulator under investigation for the treatment of RRMS.
A multiple sclerosis sufferer from North Finchley has raised nearly 5000 for charity.
Paula Sanchez, 23, who was diagnosed with the condition five months ago, gathered together celebrities and cake lovers to raise money for the Multiple Scleroisis Society during an event at the Hyatt Regency Hotel last month.
Mersey 10k runner Kelly needs you to boost MS Society funds
A WIRRAL woman will take part in the Mersey Tunnel 10k to help fund research into multiple sclerosis after her mum was diagnosed with the condition.
OHSU cloning technique could help patients with Parkinson's, diabetes, multiple sclerosis
Oregon researchers have successfully produced human embryonic stem cells using a new technique that could eventually offer hope for conditions such as Parkinson's disease.
Campath slash Lemtrada for relapsing-remitting multiple sclerosis
Campath was chemotherapy medication used in the fighting of chronic lymphocytic leukemia and was used as an off-brand, chemotherapy-type therapy for helping those with multiple sclerosis as well.
OAS Wednesday - Activating immunity to suppress autoimmunity.
Every time I see an ad for some remedy that "Helps BOOST the Immune System!" I die a little inside.
MS Walk in Corning raises $55K
On a picture-perfect spring morning, 467 people took part in Sunday's, May 5, MS Walk in downtown Corning, raising an estimated $55,000. The event was a fundraiser for the National MS Society Upstate New York Chapter.
A north Iowa woman is looking to raise awareness as she takes part in the Walk MS event this weekend.
Opexa Therapeutics Reports First Quarter 2013 Financial Results and Provides Corporate Update
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Opexa Therapeutics, Inc.
Passion to make a difference drives BioFlorida CEO
When Irish biotech firm Elan Corp. launched Tysabri to treat multiple sclerosis and other autoimmune diseases, the new drug was 50 percent more effective than any other treatment of MS.
Marathon man: Gilbert hits the road in fight against multiple sclerosis
Roughly 170 miles separate the city of Vernal, in Utah, and Steamboat Springs, Colo.
Customer Interaction Solutions
Research and Markets: Masitinib (Multiple Sclerosis) - Forecast and Market Analysis to 2022
GlobalData has released its new PharmaPoint Drug Evaluation report, Masitinib - Forecast and Market Analysis to 2022.
Can vitamin D relieve multiple sclerosis symptoms?
When the immune system attacks the insulating sheath covering your brain cells, the result is a loss of normal electrical conductivity and a myriad of symptoms - ranging from loss of vision, muscle weakness, problems walking and loss of sensation.
Higher prices for MS drug help drug firm Merck
Merck also saw stronger sales of materials for liquid-crystal displays and raised its profit forecast, saying it would achieve its 2014 goals this year.
Yadegaran: Fight multiple sclerosis with Napa's Counter Punch
A 2009 Counter Punch Rutherford-Napa Valley Cabernet Sauvignon and 2009 Counter Punch Sta.